Pravastatin Sodium

Known as: Pravastatin Sodium Salt, Pravastatin Sodium [Chemical/Ingredient], Sodium Salt, Pravastatin 
The sodium salt of pravastatin with cholesterol-lowering and potential antineoplastic activities. Pravastatin competitively inhibits hepatic… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2018
024619882018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
OBJECTIVE To investigate whether the use of pravastatin reduces the frequency of ventilator-associated pneumonia and whether it… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2010
2010
The purpose of this study was to develop and optimize formulations of mucoadhesive bilayered buccal tablets of pravastatin sodium… (More)
  • table I
  • table II
  • table III
  • figure 1
  • table IV
Is this relevant?
2001
2001
BACKGROUND AND PURPOSE Recent investigations have suggested an important role of statins in the prevention of stroke and dementia… (More)
  • figure 1
  • figure 2
Is this relevant?
2000
2000
BACKGROUND There is controversial evidence that a low serum cholesterol level is associated with an increased risk of depression… (More)
Is this relevant?
1996
1996
It has been shown previously that 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (HMG-CoA RIs) such as compactin and… (More)
Is this relevant?
1995
1995
We examined whether serum cholesterol reduction alters the lesional composition of atherosclerotic plaques. To reduce serum… (More)
Is this relevant?
1992
1992
Pravastatin sodium (pravastatin) is a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, and was… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?
1991
1991
Pravastatin sodium (PV) is a potent cholesterol-lowering agent that acts by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A… (More)
Is this relevant?
1990
1990
Pravastatin sodium, a competitive inhibitor of HMG-CoA reductase, is a new orally effective hypocholesterolaemic agent. In a two… (More)
Is this relevant?
1990
1990
Tissue selectivity of pravastatin sodium (pravastatin) in inhibition of cholesterol synthesis was investigated and its effect was… (More)
Is this relevant?